Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Behav Neurol ; 2020: 8890452, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33224311

RESUMEN

OBJECTIVE: Our study was aimed at investigating the mechanistic consequences of the upregulation of adipocyte enhancer-binding protein 1 (AEBP1) in glioblastoma (GBM). METHODS: The expression of AEBP1 in GBM was assessed by bioinformatics analysis and qRT-PCR; the effects of AEBP1 on GBM cell proliferation, migration, invasion, and tumor growth in vitro and in vivo were detected by a CCK-8 assay, colony formation assay, scratch assay, Transwell assay, and subcutaneous tumor formation, respectively. The activation of related signaling pathways was monitored using western blot. RESULTS: Tumor-related databases and bioinformatics analysis revealed that AEBP1 was highly expressed in GBM and indicated poor outcome of patients; its high expression that was also confirmed in GBM tissues and cell lines was closely related to the tumor size. The results of in vitro experiments showed that AEBP1 could significantly promote GBM cell proliferation, migration, and invasion; in vivo experiments suggested that AEBP1 could contribute to the growth of GBM tumors. AEBP1 could upregulate the level of IκBα phosphorylation, decrease IκBα expression, activate the NF-κB signaling pathway, and promote the expression of downstream oncogenes. CONCLUSION: Upregulated AEBP1 in GBM promotes GBM cell proliferation, migration, and invasion and facilitates tumor growth in vivo by activating the classical NF-κB pathway.


Asunto(s)
Glioblastoma , Carboxipeptidasas/genética , Carboxipeptidasas/metabolismo , Línea Celular Tumoral , Proliferación Celular , Regulación Neoplásica de la Expresión Génica , Glioblastoma/genética , Humanos , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Transducción de Señal
2.
Biosci Biotechnol Biochem ; 83(6): 1035-1044, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30973065

RESUMEN

Pituitary adenomas (PA) are commonly occurring benign neoplasms. Identification of molecular pathway resulting in pituitary tumorigenesis remains challenges in endocrine oncology. The present study was conducted with aim of investigating the role of microRNA-543 (miR-543) in PA development. Up-regulated miR-543 and downregulated Smad7 were observed in PA tissues. Afterwards, the specific mechanism of miR-543 and Smad7 in PA were determined with the use of ectopic expression, depletion and reporter assay experiments. Smad7 was confirmed as a target gene of miR-543. HP75 cells treated with overexpressed miR-543 exhibited increased cell proliferation, migration and invasion, while decreased cell apoptosis as well as expression of Cleaved caspase-3 and Cleaved caspase-8 were observed. Suppression of miR-543 contributed to an opposite trend to the above findings. Based on the findings, the inhibition of miR-543 was found to play a tumor suppressive role in PA through the down-regulation of Wnt/ß-catenin pathway by negatively regulating Smad7.


Asunto(s)
Adenoma/metabolismo , Adenoma/patología , Apoptosis/genética , MicroARNs/fisiología , Invasividad Neoplásica/genética , Neoplasias Hipofisarias/metabolismo , Neoplasias Hipofisarias/patología , Proteína smad7/metabolismo , Vía de Señalización Wnt , beta Catenina/metabolismo , Adulto , Caspasa 3/metabolismo , Caspasa 8/metabolismo , Línea Celular , Movimiento Celular/genética , Proliferación Celular/genética , Regulación hacia Abajo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Regulación hacia Arriba
3.
J Clin Neurosci ; 33: 217-220, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27450285

RESUMEN

Pilomyxoid astrocytoma (PMA) is a rare, low-grade glioma that is recognised as a variant of pilocytic astrocytoma. There have been few reports on this pathologic entity presenting with spontaneous haemorrhage. In this study, we report a rare case of PMA in the hypothalamic/chiasmatic region presenting with intratumoural and intraventricular haemorrhage. An external ventricular drain was urgently inserted. A ventriculo-peritoneal shunt (VP) was undergone 4weeks thereafter. The patient received fractionated Gamma Knife radiosurgery in another hospital 3weeks after the VP shunt. Three months later, subtotal resection of the tumour was performed in our hospital via a pterional approach. The pathological diagnosis was PMA. Postoperatively, no adjuvant therapy was given, and the neurologic deficits were improved. However, the presentation of endocrine deficits remained. Notably, PMAs in the hypothalamic/chiasmatic region presenting with massive intratumoural and intraventricular haemorrhage may result in a severe condition and long-term impairment of endocrine function. Long-term follow-up is required to monitor the recurrence of the tumour and endocrinopathy.


Asunto(s)
Astrocitoma/complicaciones , Ventrículos Cerebrales/patología , Neoplasias Hipotalámicas/complicaciones , Hemorragias Intracraneales/etiología , Adolescente , Astrocitoma/diagnóstico por imagen , Astrocitoma/cirugía , Ventrículos Cerebrales/diagnóstico por imagen , Ventrículos Cerebrales/cirugía , Drenaje , Humanos , Neoplasias Hipotalámicas/diagnóstico por imagen , Neoplasias Hipotalámicas/cirugía , Hemorragias Intracraneales/diagnóstico por imagen , Hemorragias Intracraneales/cirugía , Imagen por Resonancia Magnética , Masculino , Radiocirugia , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Derivación Ventriculoperitoneal
4.
Springerplus ; 5: 147, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27026844

RESUMEN

To evaluate SNPs (single nucleotide polymorphism) in PROC (protein C gene) associated with pulmonary embolism (PE) susceptibility in North Chinese Han population. A case-control study design was used, and patients with PE and healthy participants were enrolled from the Emerging Department of the several hospitals in Weifang, Shandong, China. SNPs in PROC were genotyped using Mass ARRAY system. The allele frequency of rs199469469 was significantly different between PE patients and the control [OR (95 % CI) = 5.00 (1.66-15.12), P = 0.004], and the difference remained significantly after controlling for age and gender [OR (95 % CI) = 5.34 (1.47-19.39), P = 0.011). The G(del)G in the haplotype includes rs1799809|rs199469469|rs2069928 was of a significantly difference (P = 0.016) among PE patients and the controls, and remained significant (P = 0.015) after adjustment for age and sex. Our study reports that PROC SNPs (rs199469469) might be associated with PE susceptibility, with the G allele of rs199469469 serving as the protective factors for incidence of PE. These findings may contribute to the understanding and primary prevention of PE.

5.
Zhonghua Liu Xing Bing Xue Za Zhi ; 30(5): 507-10, 2009 May.
Artículo en Chino | MEDLINE | ID: mdl-19799151

RESUMEN

OBJECTIVE: To analyze the risk factors that associated with survival of postoperative patients with glioma. METHODS: From 2000 to 2006, 522 patients were enrolled in our hospital and were analyzed related risk factors by using Kaplan-Meier's Product-Limit Survival Estimates method, log-rank test and Cox's proportional-hazards model. Analysis of data were performed in SAS 9.1. Results In univariate analysis, age, sex, extent of resection in surgery and pathological grades appeared to be associated with survival rate of the patients (alpha = 0.05). Cox regression analysis showed these four factors were also significant (HR value 0.811, 1.553, 1.634 and 1.429, respectively). Multivariate Cox regression model also showed that age, pathological grades and extent of resection in surgery were main factors affecting the survival of the patients while HR value increased with the ascending class (2.349, 3.826, and 5.062, respectively)with only subtotal excision enter the model (HR = 1.459). Other factors had no statistical importance on survival rate. CONCLUSION: Age, extent of resection in surgery, pathological grades, chemotherapy after surgery, and radiotherapy after surgery might associate with the prognosis of the patients with glioma.


Asunto(s)
Neoplasias Encefálicas/mortalidad , Glioma/mortalidad , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias Encefálicas/patología , Niño , Preescolar , Femenino , Estudios de Seguimiento , Glioma/patología , Humanos , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Pronóstico , Modelos de Riesgos Proporcionales , Factores de Riesgo , Tasa de Supervivencia , Resultado del Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA